Cargando…

Update on different aspects of HCV variability: focus on NS5B polymerase

The study of hepatitis C virus (HCV) genotypes/subtypes, quasispecies and recombinants obtained by virus genome sequencing are important for epidemiological studies, to trace the source of infection, for development of new direct acting antivirals (DAAs) therapy and for understanding antiviral selec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marascio, Nadia, Torti, Carlo, Liberto, Maria Carla, Focà, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160895/ https://www.ncbi.nlm.nih.gov/pubmed/25234810 http://dx.doi.org/10.1186/1471-2334-14-S5-S1

Ejemplares similares

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
por: Zicca, Emilia, et al.
Publicado: (2014)

Update on epidemiology of HCV in Italy: focus on the Calabria Region
por: Marascio, Nadia, et al.
Publicado: (2014)

Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
por: Liberto, Maria Carla, et al.
Publicado: (2022)

Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients
por: Marascio, Nadia, et al.
Publicado: (2016)

Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry
por: Quirino, Angela, et al.
Publicado: (2014)

Gut Inflammation and Immunity: What Is the Role of the Human Gut Virome?
por: Focà, Alfredo, et al.
Publicado: (2015)

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
por: Marascio, Nadia, et al.
Publicado: (2019)

Towards HCV extinction with modern HCV treatment? “Yes we can!”
por: Torti, C, et al.
Publicado: (2012)

Challenging clinical cases in HCV infection
por: Strazzulla, Alessio, et al.
Publicado: (2014)

Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
por: Kaushik-Basu, Neerja, et al.
Publicado: (2008)

Classification of HCV NS5B Polymerase Inhibitors Using Support Vector Machine
por: Wang, Maolin, et al.
Publicado: (2012)

Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals
por: Strazzulla, Alessio, et al.
Publicado: (2014)

The Role of the Microbiota Gut–Liver Axis during HCV Chronic Infection: A Schematic Overview
por: Marascio, Nadia, et al.
Publicado: (2022)

Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series
por: Mazzitelli, Maria, et al.
Publicado: (2018)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
por: Karpiński, Tomasz M., et al.
Publicado: (2023)

Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients
por: Mazzitelli, Maria, et al.
Publicado: (2018)

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients
por: Paolucci, Stefania, et al.
Publicado: (2013)

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir
por: Berger, Kristi L., et al.
Publicado: (2016)

Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region
por: Matera, Giovanni, et al.
Publicado: (2018)

Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice
por: Marascio, Nadia, et al.
Publicado: (2022)

Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2012)

Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2021)

A Cell-Based Assay for RNA Synthesis by the HCV Polymerase Reveals New Insights on Mechanism of Polymerase Inhibitors and Modulation by NS5A
por: Ranjith-Kumar, C. T., et al.
Publicado: (2011)

Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
por: Costantino, Angela, et al.
Publicado: (2015)

Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria region
por: Liberto, MC, et al.
Publicado: (2012)

Performance of NS3, NS5a AND NS5b Hepatitis C Virus (HCV) Antiviral Resistance Sequencing Assays
por: Nutt, Jamie, et al.
Publicado: (2017)

The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function
por: Hebner, Christy M., et al.
Publicado: (2012)

Cell Penetrable Humanized-VH/V(H)H That Inhibit RNA Dependent RNA Polymerase (NS5B) of HCV
por: Thueng-in, Kanyarat, et al.
Publicado: (2012)

QSAR study of HCV NS5B polymerase inhibitors using the genetic algorithm-multiple linear regression (GA-MLR)
por: Rafiei, Hamid, et al.
Publicado: (2016)

Insight into the drug resistance mechanisms of GS-9669 caused by mutations of HCV NS5B polymerase via molecular simulation
por: Han, Di, et al.
Publicado: (2021)

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
por: Demetriou, Victoria L, et al.
Publicado: (2010)

Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent
por: Kwon, Hyock Joo, et al.
Publicado: (2015)

Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization
por: Lang Kuhs, Krystle A., et al.
Publicado: (2012)

Correction: Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization
por: Lang Kuhs, Krystle A., et al.
Publicado: (2013)

A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
por: Isken, Olaf, et al.
Publicado: (2015)

Future research and collaboration: the “SINERGIE” project on HCV (South Italian Network for Rational Guidelines and International Epidemiology)
por: Torti, C, et al.
Publicado: (2012)

Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liver
por: Zhang, Jin, et al.
Publicado: (2019)

Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
por: Isken, Olaf, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_535slln46fj3qe3ffluicj59er